Difference between revisions of "Zaidi AH, et al. Ann. Surg. (2017) cited as Ref 365 in DOI: 10.1038/s41392-020-0110-5 (Q9628)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: PubMed ID (P140): 27471841, #quickstatements; #temporary_batch_1590001671040)
(‎Created claim: Page(s) (P105): 91-98, #quickstatements; #temporary_batch_1590074839150)
 
(4 intermediate revisions by the same user not shown)
Property / Publication Date
 +
2017
Timestamp+2017-01-01T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 year
Before0
After0
Property / Publication Date: 2017 / rank
 +
Normal rank
Property / Published In Name String
 +
Ann. Surg.
Property / Published In Name String: Ann. Surg. / rank
 +
Normal rank
Property / Volume
 +
266
Property / Volume: 266 / rank
 +
Normal rank
Property / title
 +
PI3K/mTOR dual inhibitor LY3023414 demonstrates potent antitumor efficacy against esophageal adenocarcinoma in a rat model (English)
Property / title: PI3K/mTOR dual inhibitor LY3023414 demonstrates potent antitumor efficacy against esophageal adenocarcinoma in a rat model (English) / rank
 +
Normal rank
Property / Page(s)
 +
91-98
Property / Page(s): 91-98 / rank
 +
Normal rank

Latest revision as of 15:39, 21 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
Zaidi AH, et al. Ann. Surg. (2017) cited as Ref 365 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    Zaidi AH
    0 references
    0 references
    2017
    0 references
    Ann. Surg.
    0 references
    266
    0 references
    PI3K/mTOR dual inhibitor LY3023414 demonstrates potent antitumor efficacy against esophageal adenocarcinoma in a rat model (English)
    0 references
    91-98
    0 references